Prothena Plc Stock Alpha and Beta Analysis

PRTA Stock  USD 15.14  0.60  3.81%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Prothena plc. It also helps investors analyze the systematic and unsystematic risks associated with investing in Prothena Plc over a specified time horizon. Remember, high Prothena Plc's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Prothena Plc's market risk premium analysis include:
Beta
0.58
Alpha
(0.27)
Risk
6.37
Sharpe Ratio
0.0046
Expected Return
0.0293
Please note that although Prothena Plc alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Prothena Plc did 0.27  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Prothena plc stock's relative risk over its benchmark. Prothena plc has a beta of 0.58  . As returns on the market increase, Prothena Plc's returns are expected to increase less than the market. However, during the bear market, the loss of holding Prothena Plc is expected to be smaller as well. As of December 29, 2024, Book Value Per Share is expected to decline to 6.66. In addition to that, Tangible Book Value Per Share is expected to decline to 6.69.

Enterprise Value

618.19 Million

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Prothena Plc Backtesting, Prothena Plc Valuation, Prothena Plc Correlation, Prothena Plc Hype Analysis, Prothena Plc Volatility, Prothena Plc History and analyze Prothena Plc Performance.
For information on how to trade Prothena Stock refer to our How to Trade Prothena Stock guide.

Prothena Plc Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Prothena Plc market risk premium is the additional return an investor will receive from holding Prothena Plc long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Prothena Plc. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Prothena Plc's performance over market.
α-0.27   β0.58

Prothena Plc expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Prothena Plc's Buy-and-hold return. Our buy-and-hold chart shows how Prothena Plc performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Prothena Plc Market Price Analysis

Market price analysis indicators help investors to evaluate how Prothena Plc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Prothena Plc shares will generate the highest return on investment. By understating and applying Prothena Plc stock market price indicators, traders can identify Prothena Plc position entry and exit signals to maximize returns.

Prothena Plc Return and Market Media

The median price of Prothena Plc for the period between Mon, Sep 30, 2024 and Sun, Dec 29, 2024 is 16.46 with a coefficient of variation of 10.8. The daily time series for the period is distributed with a sample standard deviation of 1.73, arithmetic mean of 16.03, and mean deviation of 1.39. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
Acquisition by Walker Karin L of 54000 shares of Prothena Plc at 30.3 subject to Rule 16b-3
10/23/2024
2
Disposition of 66 shares by Walker Karin L of Prothena Plc at 68.9572 subject to Rule 16b-3
10/25/2024
3
Prothena Co. plc Given Consensus Recommendation of Moderate Buy by Brokerages
11/12/2024
4
EcoR1 Capital, LLC Increases Stake in Crinetics Pharmaceuticals Inc
11/15/2024
5
Prothenas SWOT analysis high-risk pipeline stock faces crucial readouts
12/04/2024
6
Wellington Management Group LLP Purchases 539,359 Shares of Prothena Co. plc - MarketBeat
12/11/2024
7
Roches Phase IIb Study of Prasinezumab Missed Primary Endpoint, But Suggests Possible Clinical Benefit in Early-Stage Parkinsons Disease
12/19/2024
8
This SP Global Analyst Begins Coverage On A Bullish Note Here Are Top 5 Initiations For Friday
12/20/2024
9
EcoR1 Capital, LLC Increases Stake in Zymeworks Inc
12/26/2024

About Prothena Plc Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Prothena or other stocks. Alpha measures the amount that position in Prothena plc has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2021 2023 2024 (projected)
Graham Number18.9525.6116.12
Receivables Turnover869.4417.7116.83

Prothena Plc Upcoming Company Events

As portrayed in its financial statements, the presentation of Prothena Plc's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Prothena Plc's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Prothena Plc's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Prothena Plc. Please utilize our Beneish M Score to check the likelihood of Prothena Plc's management manipulating its earnings.
22nd of February 2024
Upcoming Quarterly Report
View
2nd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
22nd of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with Prothena Plc

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Prothena plc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Prothena Plc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Prothena Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Prothena Plc Stock:
Prothena Plc technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Prothena Plc technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Prothena Plc trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...